Home › Immunoglobulin Light-chain Amyloidosis › Texas
Immunoglobulin Light-chain Amyloidosis clinical trials in Texas
3 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in Texas.
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
- UT Southwestern Medical Center, Dallas
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05145816Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- Houston Methodist San Jacinto Hospital, Baytown
- Houston Methodist Cypress Hospital, Cypress
- Houston Methodist Hospital, Houston
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06022939Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- UT Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas
RecruitingObservational study
Ages 40 and older · All sexes · Updated Aug 6, 2025 · NCT06365060From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.